ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Model N Launches Data nSights: Real-Time Analytics to Drive Action and Optimize Net Revenue

REDWOOD CITY, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Model N, the leader in revenue optimization and compliance for life sciences and high-tech companies, announced Data nSights, an integrated data and analytics solution. Data nSights provides timely access to curated, artificial intelligence (AI) and analytic-ready data, along with no-code data exploration and a growing library of comprehensive insights for life sciences revenue management.

As the next generation of Model N’s data and analytics capabilities, Data nSights automates data pipelines to reduce manual processing and organizes and provides a comprehensive foundation for actionable insights.  

Pharmaceutical and medical technology companies often struggle to extract value from the vast amounts of revenue management data. Data nSights addresses this challenge by streamlining data integration, enabling faster, more strategic decision-making to prevent revenue leakage. 

“Life sciences manufacturers often invest in data infrastructure and consultants, yet still face delayed visibility and fragmented information,” said Bret Connor, Model N Chief Executive Officer. “Data nSights shifts the focus from data preparation to strategic decision-making that drives revenue, profitability, and compliance. Early customer feedback confirms strong demand, echoing our 2025 State of Revenue Report, which found nearly half of revenue leaders are prioritizing data integration and analytics. By harmonizing data across the revenue management lifecycle, this solution lays the groundwork for efficient analytics and scalable AI integrations.”

The Data nSights launch follows an Early Access Program with select customers in hands-on testing and refinement of the platform prior to general availability. Leading life sciences manufacturers participated in the program, providing valuable feedback. This input helped tune the product and its roadmap, paving the way for scaled adoption across the industry and Model N’s leading-edge customer base.

With Data nSights, Model N responds to customer needs by transforming complex revenue management data into actionable intelligence through three distinct capabilities:

  • Insights Library: Pre-built, interactive analytics dashboards covering key business areas.
  • Self-Service No-Code BI: Capability to create analytics without technical expertise.
  • Dimensional Data Stores: Curated datasets accelerate analytics and connect directly to in-house data and BI platforms.

By equipping life sciences manufacturers with advanced tools and a forward-looking platform, Model N empowers customers to unlock new opportunities and bring life-changing products to the world more efficiently.

For more information about Data nSights, please visit modeln.com

###

About Model N
Model N is the leader in revenue optimization and compliance for pharmaceutical, medtech and high-tech innovators. For more than 25 years, we have helped customers maximize revenue, streamline operations, and maintain compliance through cloud-based software, value-added services, and data-driven insights. With a focus on innovation and customer success, Model N empowers life sciences and high-tech manufacturers to bring life-changing products to the world more efficiently and profitably. Model N is trusted by over 150 of the world’s leading companies across more than 120 countries. For more information, visit www.modeln.com.


PANBlast for Model N
modeln@panblastpr.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  236.62
-1.56 (-0.65%)
AAPL  256.23
-1.98 (-0.77%)
AMD  231.69
+3.77 (1.65%)
BAC  52.45
-0.15 (-0.28%)
GOOG  330.29
-2.88 (-0.86%)
META  623.50
+2.70 (0.43%)
MSFT  458.48
+1.82 (0.40%)
NVDA  187.50
+0.45 (0.24%)
ORCL  187.31
-2.54 (-1.34%)
TSLA  436.91
-1.66 (-0.38%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.